Innoviva, Inc. (INVA)

NASDAQ: INVA · Real-Time Price · USD

22.32

+0.29 (1.32%)

At close: Mar 9, 2026, 4:00 PM EDT

23.33

+1.01 (4.53%)

Pre-market: Mar 10, 2026, 4:42 AM EDT

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Biotechnology	411.33M	358.71M	310.46M	331.34M	391.87M
Biotechnology Growth	14.67%	15.54%	-6.30%	-15.45%	16.35%
Total	411.33M	358.71M	310.46M	331.34M	391.87M
Total Growth	14.67%	15.54%	-6.30%	-15.45%	16.35%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Great Britain	236.48M	241.73M	238.85M	311.65M	391.87M
Great Britain Growth	-2.17%	1.21%	-23.36%	-20.47%	19.91%
Total	236.48M	241.73M	238.85M	311.65M	391.87M
Total Growth	-2.17%	1.21%	-23.36%	-20.47%	19.91%

Source: S&P Global Market Intelligence.